Abstract
Lung cancer is the leading cause of cancer death worldwide1. Recent data suggest that tumor-associated inflammatory cells may modify lung tumor growth and invasiveness2,3. To determine the role of neutrophil elastase (encoded by Elane) on tumor progression, we used the loxP-Stop-loxP K-rasG12D (LSL–K-ras) model of mouse lung adenocarcinoma4 to generate LSL–K-ras-Elane−/− mice. Tumor burden was markedly reduced in LSL–K-ras-Elane−/− mice at all time points after induction of mutant K-ras expression. Kaplan-Meier survival analysis showed that whereas all LSL–K-ras-Elane+/+ mice died, none of the mice lacking neutrophil elastase died. Neutrophil elastase directly induced tumor cell proliferation in both human and mouse lung adenocarcinomas by gaining access to an endosomal compartment within tumor cells, where it degraded insulin receptor substrate-1 (IRS-1). Immunoprecipitation studies showed that, as neutrophil elastase degraded IRS-1, there was increased interaction between phosphatidylinositol 3-kinase (PI3K) and the potent mitogen platelet-derived growth factor receptor (PDGFR), thereby skewing the PI3K axis toward tumor cell proliferation. The inverse relationship identified between neutrophil elastase and IRS-1 in LSL–K-ras mice was also identified in human lung adenocarcinomas, thus translating these findings to human disease. This study identifies IRS-1 as a key regulator of PI3K within malignant cells. Additionally, to our knowledge, this is the first description of a secreted proteinase gaining access to the inside of a cell and altering intracellular signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jemal, A. et al. Cancer statistics 2009. CA Cancer J. Clin. 59, 225–249 (2009).
Karin, M. Inflammation and cancer: the long reach of Ras. Nat. Med. 11, 20–21 (2005).
Coussens, L.M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
Jackson, E.L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243–3248 (2001).
Sparmann, A. & Bar-Sagi, D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447–458 (2004).
Haqqani, A.S., Sandhu, J.K. & Birnboim, H.C. Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors. Neoplasia 2, 561–568 (2000).
Nozawa, H., Chiu, C. & Hanahan, D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. USA 103, 12493–12498 (2006).
Ji, H. et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 25, 2105–2112 (2006).
Bellocq, A. et al. Neutrophil alveolitis in bronchioloalveolar carcinoma. Am. J. Pathol. 152, 83–92 (1998).
Foekens, J.A. et al. The prognostic value of PMN leukocyte elastase in patients with primary breast cancer. Cancer Res. 63, 337–341 (2003).
Lee, W.L. & Downey, G.P. Leukocyte Elastase: Physiological functions and role in acute lung injury. Am. J. Respir. Crit. Care Med. 164, 896–904 (2001).
Belaaouaj, A. et al. Mice lacking neutrophil elastase reveal impaired host defense against Gram-negative bacterial sepsis. Nat. Med. 4, 615–618 (1998).
Weinrauch, Y., Drujan, D., Shapiro, S.D., Weiss, J. & Zychlinsky, A. Neutrophil elastase targets virulence factors of enterobacteria. Nature 417, 91–94 (2002).
Lee, S., Jilan, S.M., Nikolova, G.V., Carpizo, D. & Iruela-Arispe, M.L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681–691 (2005).
Wada, Y. et al. Neutrophil elastase induces cell proliferation and migration by the release of TGFα, PDGF and VEGF in esophageal cell lines. Oncol. Rep. 17, 161–167 (2007).
Liou, T.G. & Campbell, E.J. Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. J. Immunol. 157, 2624–2631 (1996).
Rubino, M. et al. Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes. J. Biol. Chem. 275, 3745–3748 (2000).
Antoniades, H.N. et al. Malignant epithelial cells in primary human lung carcinomas coexpress in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products. Proc. Natl. Acad. Sci. USA 89, 3942–3946 (1992).
Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839–850 (2006).
Cully, M., You, H., Levine, A. & Mak, T.W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184–192 (2006).
Yamauchi, T. et al. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J. Biol. Chem. 273, 15719–15726 (1998).
Navé, B.T., Haigh, R.J., Hayward, A.C., Siddle, K. & Shepherd, P.R. Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3–L1 adipocytes. Biochem. J. 318, 55–60 (1996).
Dearth, R.K., Cui, X., Kim, H.-J., Hadsell, D.L. & Lee, A.V. Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle 6, 705–713 (2007).
Gual, P., Le Marchand-Brustel, Y. & Tanti, J.F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99–109 (2005).
Han, C.H. et al. Clinical significance of insulin receptor substrate-1 down-regulation in non-small cell lung cancer. Oncol. Rep. 16, 1205–1210 (2006).
Sentinelli, F. et al. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARγ agonist restores cell signaling and differentiation. J. Endocrinol. 188, 271–285 (2006).
Neuhausen, S.L. et al. Prostate cancer risk and IRS-1, IRS2, IGF1, and INS polymorphisms: strong association of IRS-1 G972R variant and cancer risk. Prostate 64, 168–174 (2005).
Shapiro, S.D. et al. Neutrophil elastase contributes to cigarette smoke–induced emphysema in mice. Am. J. Pathol. 163, 2329–2335 (2003).
Wilson, D.O. et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am. J. Respir. Crit. Care Med. 178, 738–744 (2008).
Houghton, A.M., Mouded, M. & Shapiro, S.D. Common origins of lung cancer and COPD. Nat. Med. 14, 1023–1024 (2008).
Peto, R., Chen, Z.M. & Boreham, J. Tobacco: the growing epidemic. Nat. Med. 5, 15–17 (1999).
Tu, Y., Liang, L., Frank, S.J. & Wu, C. Src homology 3 domain–dependent interaction of Nck-2 with insulin receptor substrate-1. Biochem. J. 354, 315–322 (2001).
Acknowledgements
This work was supported by grants K08HL085286 and RO1HL054853 from the US National Institutes of Health National Heart, Lung, and Blood Institute (A.M.H. and S.D.S.) and by grant RO1DK058259 from the US National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (S.J.F.). ONO Pharmaceutical provided the ONO-5046. LSL–K-ras mice were provided by T. Jacks (Massachusetts Institute of Technology). AdenoCre was obtained from the University of Iowa Gene Transfer Vector Core. We would like to recognize members of the Shapiro lab for their assistance and comments regarding the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
A.M.H. and S.D.S. designed the study and interpreted all data. A.M.H., D.M.R., H.J., A.D.G., E.E.E., H.E.M., D.B.S., L.A.M., C.R.K., K.M.J., K.A.B. and M.M. performed the experiments. S.R.L. performed statistical analyses. S.J.F. provided the IRS-1 expression vector and assisted with data interpretation. K.K.W. participated in study design and data interpretation. A.M.H. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4, Supplementary Table 1 and Supplementary Methods (PDF 1104 kb)
Rights and permissions
About this article
Cite this article
Houghton, A., Rzymkiewicz, D., Ji, H. et al. Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16, 219–223 (2010). https://doi.org/10.1038/nm.2084
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2084
This article is cited by
-
Elevated first-trimester neutrophil elastase and proteinase 3 increase the risk of gestational diabetes mellitus and adverse fetal outcomes
Reproductive Biology and Endocrinology (2024)
-
Neutrophils in cancer: dual roles through intercellular interactions
Oncogene (2024)
-
The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications
Molecular Cancer (2023)
-
Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
Breast Cancer Research (2023)
-
The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis
Cancer Cell International (2023)